-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Invasive mycosis (IFD) is a common and potentially life-threatening complication in the haematology-oncology population, with patients receiving remission-induced therapy for acute myeloid leukemia (AML) having a higher
risk of developing invasive mycosis (IFD).
The study was a single-center retrospective study of patients with
bone marrow malignancies who received intensive chemotherapy continuously between 2014 and 2021.
Figure 1.
Figure 2: Overview
of study inclusion.
Figure 3.
Figure 4.
A total of 192 patients with bone marrow malignancies received 300 courses of intensive chemotherapy
.
In summary, diagnostic-driven therapy, without universal aggressive mold prevention, is a viable strategy for IFD therapy and can limit unnecessary antifungal therapy during intensive chemotherapy
.
Original Source:
De Kort EA, Buil JB, Schalekamp S, Schaefer-Prokop C, Verweij PE, Schaap NPM, Blijlevens NMA, Van der Velden WJFM.
